The MoldRx Genetic Risk Test for Mold Toxicity offers Canadian families a clinician-guided, privacy-focused way to understand their genetic susceptibility to mold-related illness. This at-home cheek swab test analyzes HLA-DR and HLA-DQ gene variants, which influence how effectively the immune system recognizes and clears mold toxins—an important factor, as about one in four people may have genetic patterns linked to slower toxin clearance. Results are delivered securely online in plain language within 2–3 weeks, providing actionable guidance for discussion with your healthcare provider. MoldRx emphasizes responsible, evidence-cited education without fear-based messaging or diagnostic claims, and all results are intended for informational purposes only. The service is designed to support informed, calm next steps, not to diagnose or treat medical conditions.

• What genes does the MoldRx Genetic Risk Test analyze? * The test analyzes HLA-DR and HLA-DQ gene variants, which play a role in immune recognition and toxin clearance.
• Who should consider this test? * Anyone in Canada with persistent symptoms after mold exposure, a history of water damage, or a desire to understand their genetic susceptibility—especially if remediation hasn’t fully resolved concerns.
• Will this test tell me if I have mold illness? * No. The test identifies genetic susceptibility, not a diagnosis, and is meant to support conversations with your healthcare provider.
• How is the sample collected? * The test uses a simple at-home cheek swab, which is mailed to a third-party lab for analysis.
• How long does it take to get results? * Results are typically available within 2–3 weeks and are delivered securely online with clear interpretation and next-step guidance.

• Complete the intake
• Talk to a clinician
• Learn more at https://www.moldrx.com/